QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

Search

Faes Farma SA

Atvērts

4.595 -0.33

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.52

Max

4.615

Galvenie mērījumi

By Trading Economics

Ienākumi

-4.4M

24M

Pārdošana

-78M

154M

P/E

Sektora vidējais

13.162

105.69

Peļņas marža

15.516

Darbinieki

1,894

EBITDA

-16M

33M

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

72M

1.4B

Iepriekšējā atvēršanas cena

4.93

Iepriekšējā slēgšanas cena

4.595

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

Faes Farma SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 17. nov. 18:59 UTC

Galvenie tirgus virzītāji

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

2025. g. 17. nov. 23:40 UTC

Tirgus saruna

Gold Consolidates Amid Mixed Signals -- Market Talk

2025. g. 17. nov. 23:34 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2025. g. 17. nov. 22:58 UTC

Tirgus saruna

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

2025. g. 17. nov. 22:46 UTC

Tirgus saruna

Risk Assets Set to Have a Strong 2026 -- Market Talk

2025. g. 17. nov. 22:06 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

2025. g. 17. nov. 22:02 UTC

Peļņas

Trip.com Group 3Q Rev $2.6B >TCOM

2025. g. 17. nov. 22:02 UTC

Peļņas

Trip.com Group 3Q Adj EPS $3.87 >TCOM

2025. g. 17. nov. 22:02 UTC

Peļņas

Trip.com Group 3Q EPS $4.02 >TCOM

2025. g. 17. nov. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 17. nov. 21:40 UTC

Peļņas

James Hardie Industries 2Q Adj EPS 26c >JHX

2025. g. 17. nov. 21:40 UTC

Peļņas

James Hardie Industries 2Q Loss/Shr 10c >JHX

2025. g. 17. nov. 21:39 UTC

Peļņas

James Hardie Industries 2Q Sales $1.29B >JHX

2025. g. 17. nov. 21:38 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025. g. 17. nov. 21:38 UTC

Peļņas

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

2025. g. 17. nov. 21:10 UTC

Peļņas

XP Inc. 3Q EPS BRL2.47 >XP

2025. g. 17. nov. 21:10 UTC

Peļņas

XP Inc. 3Q Rev BRL4.67B >XP

2025. g. 17. nov. 20:20 UTC

Tirgus saruna

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

2025. g. 17. nov. 20:12 UTC

Tirgus saruna

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

2025. g. 17. nov. 20:12 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. nov. 20:09 UTC

Tirgus saruna

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

2025. g. 17. nov. 19:29 UTC

Tirgus saruna

Gold Slide Continues to Start Week -- Market Talk

2025. g. 17. nov. 19:16 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025. g. 17. nov. 18:20 UTC

Iegādes, apvienošanās, pārņemšana

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

2025. g. 17. nov. 16:45 UTC

Iegādes, apvienošanās, pārņemšana

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

2025. g. 17. nov. 16:16 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025. g. 17. nov. 16:15 UTC

Peļņas

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

2025. g. 17. nov. 15:40 UTC

Iegādes, apvienošanās, pārņemšana

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

2025. g. 17. nov. 15:22 UTC

Iegādes, apvienošanās, pārņemšana

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

2025. g. 17. nov. 15:19 UTC

Tirgus saruna

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Salīdzinājums

Cenas izmaiņa

Faes Farma SA Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

4.15 / 4.275Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Very Strong Bullish Evidence

Ilgtermiņā

Strong Bullish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
help-icon Live chat